Search Within

Molecular Pharmacology and Chemistry Program Faculty

Formats
  1. Journal Article (4981)
  2. Meeting Abstract (2012)
  3. Book Section (218)
  4. Conference Paper (122)
  5. Review (81)
  6. Editorial (50)
  7. Book Whole (30)
  8. Research Letter (15)
  9. Correspondence (8)
  10. Miscellaneous (6)
  11. Guidelines (2)
Groups
  1. Sloan Kettering Institute Faculty (7525)
  2. GSK Faculty (4733)
  3. Department of Medicine (2732)
  4. Surgery (2099)
  5. Center for Hematologic Malignancies (1836)
  6. Radiology, Department of (1826)

More Groups

People
  1. Murray Brennan (1060)
  2. Steven Larson (962)
  3. Peter Scardino (672)
  4. Michel Sadelain (586)
  5. Samuel Danishefsky (539)
  6. David Scheinberg (502)

More People

Years
  1. 2025 (67)
  2. 2024 (98)
  3. 2023 (122)
  4. 2022 (151)
  5. 2021 (155)
  6. 2020 (162)

More Years

Publications
  1. Blood (384)
  2. Journal of Nuclear Medicine (383)
  3. Cancer Research (340)
  4. Journal of Clinical Oncology (316)
  5. Annals of Surgical Oncology (181)
  6. International Journal of Radiation Oncology, Biology, Physics (176)

More Publications

Publishers
  1. American Association for Cancer Research (713)
  2. Elsevier Inc. (674)
  3. Nature Publishing Group (493)
  4. Springer (468)
  5. American Chemical Society (444)
  6. Elsevier Science, Inc. (406)

More Publishers

Results (7525)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Histology-specific prognostication for radiation-associated soft tissue sarcoma
    Journal Article

    Bartlett, E. K.; Sharma, A.; Seier, K.; Antonescu, C. R.; Agaram, N. P.; Jadeja, B.; Rosenbaum, E.; Chi, P.; Brennan, M. F.; Qin, L. X.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • Nuclear oncology: From pathophysiology to clinical applications. 3rd ed
    Book Whole


    Springer (2022)

    Fulltext@MSK | Save
  • Diagnostic applications of nuclear medicine: Tumors of the liver and biliary tract
    Book Section

    Raoof, M.; Larson, S. M.; Fong, Y.
    In Volterrani, D.; Erba, P. A.; Strauss, H. W.; Mariani, G.; Larson, S. M. (Eds.) Nuclear Oncology: From Pathophysiology to Clinical Applications. 3rd ed (2022)

    Fulltext@MSK | Save
  • Cancer biology of molecular imaging
    Book Section

    Larson, S. M.
    In Volterrani, D.; Erba, P. A.; Strauss, H. W.; Mariani, G.; Larson, S. M. (Eds.) Nuclear Oncology: From Pathophysiology to Clinical Applications. 3rd ed (2022)

    Fulltext@MSK | Save
  • LDH inhibition improves response to CTLA-4 blockade by enhancing effector T cell activity and impairing regulatory T cell suppression
    Meeting Abstract

    Verma, S.; Serganova, I.; Budhu, S.; Dong, L.; Mangarin, L.; Ko, M.; Blasberg, R.; Zappasodi, R.; Wolchok, J.; Merghoub, T.
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Estrogen receptor expression and ER dependent breast tumor growth are dependent on translation initiation factor EIF4A
    Meeting Abstract

    Boyer, J. A.; Dorso, M. A.; Amor, C.; Reiter, J.; Xu, J.; de Stanchina, E.; Wendel, H. G.; Chandarlapaty, S.; Rosen, N.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • SMYD2 regulates chromatin modifier KMT2D in ER+/PIK3CA mutant breast cancer
    Meeting Abstract

    Blawski, R.; Sallaku, M.; Guo, X.; Kittane, S.; Scaltriti, M.; Luo, M.; Toska, E.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Self-assembling and disassembling (SADA) domain is critical to the binding, and anti-tumor efficacy of GD2-SADA
    Meeting Abstract

    Santich, B. H.; Kjellev, S. L.; Cheal, S.; Wang, L.; Gillberg, M.; Vadlamudi, M.; Ouattara, A. A.; Liebenberg, N.; Larsen, L. F.; Veach, D. R.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Migration of V600E-expressing cells is suppressed by ERK-dependent feedback inhibition of RAC1 and rescued in melanoma by secondary mutations
    Meeting Abstract

    Gadal, S.; Boyer, J. A.; Li, H.; Fan, N.; Chan, E.; Romin, Y.; De Stanchina, E.; Yeager, R.; Bosenberg, M.; Todorova, K. M.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • SUV39H1 disruption enhances the persistence and anti-tumor efficacy of CD28-costimulated human CAR T cells
    Meeting Abstract

    Jain, N.; Zhao, Z.; Koche, R.; Gozlan, Y.; Brocks, D.; Raveh-Sadka, T.; Wells, D.; Dobrin, A.; Shi, Y.; Lopez, M.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save